Screener
Kymera Therapeutics KYMR Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's invested capital?
- Kymera Therapeutics (KYMR) reported invested capital of $1.46B in Q2 2026.
- How has Kymera Therapeutics's invested capital changed year-over-year?
- Kymera Therapeutics's invested capital increased by 102.5% year-over-year, from $723.28M to $1.46B.
- What is the long-term trend for Kymera Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Kymera Therapeutics's invested capital has grown at a 36.9% compound annual growth rate (CAGR), from $271.57M to $1.31B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Kymera Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude